News
- Author:
- Steve Stiles
Publish date: March 23, 2023
The agency has okayed evinacumab-dgnb for patients aged 5-11 with homozygous familial hypercholesterolemia.
News
- Author:
- Steve Stiles
Publish date: March 6, 2023
Patient recovery at 12 weeks and safety outcomes were similar for the two techniques in patients with degenerative mitral valve disease. But the mi...
News
- Author:
- Steve Stiles
Publish date: March 4, 2023
Is myocardial viability testing for guiding PCI decisions currently used in the best way? A secondary analysis from the main trial suggests not.
News
- Author:
- Steve Stiles
Publish date: February 23, 2023
Long-term rhythm monitoring in a trial revealed six times as much bradycardia as was diagnosed in a usual-care clinical setting. What are the manag...
News
- Author:
- Steve Stiles
Publish date: February 14, 2023
Serial NT-proBNP assays could potentially identify which of those without clinical disease might most benefit from heart-failure preventive therapi...
News
- Author:
- Steve Stiles
Publish date: February 9, 2023
It was just as prevalent but with better outcomes as transcatheter mitral valve repair emerged to take on high-risk cases. But more than just a shi...
News
- Author:
- Steve Stiles
Publish date: February 6, 2023
A study challenges the dogma of beta-blockers for HF with preserved ejection fraction. For now, the strategy might only be for HFpEF patients alrea...
News
- Author:
- Steve Stiles
Publish date: February 3, 2023
Non–MRI-conditional devices need a few adjustments before imaging but still reliably deliver therapy.
News
- Author:
- Steve Stiles
Publish date: January 30, 2023
The risk for angioedema rises when switching from an ARB or ACE inhibitor to ARNI, observational data suggest.
News
- Author:
- Steve Stiles
Publish date: January 27, 2023
A speech at the Society of Thoracic Surgeons’ annual meeting, delivered by its outgoing president, sparked outrage and dismay on social media and p...
News
- Author:
- Steve Stiles
Publish date: January 26, 2023
A new meta-analysis of trials comparing TAVI to surgery for aortic valve stenosis highlights a high rate of potential bias in the trials.
News
- Author:
- Steve Stiles
Publish date: January 24, 2023
“PCSK9 inhibition may represent a novel therapeutic pathway in addition to currently recommended therapeutic approaches for severe COVID-19.”
News
- Author:
- Steve Stiles
Publish date: January 5, 2023
The mental health conditions were more common in women than in men and were closely linked to enduring hostile work environments and other strains ...
News
- Author:
- Steve Stiles
Publish date: December 12, 2022
In top-line results, high-risk patients with statin intolerance taking the lipid-lowering agent showed a significant decline in risk for CV events ...
News
- Author:
- Steve Stiles
Publish date: December 7, 2022
Electronic ‘nudges’ that promote new statin prescriptions seemed most effective when sent to patients as well as their primary care doctors in a ra...
